Department of Urology, Indiana University/IU Health Physicians, Indianapolis, IN.
Department of Urology, Indiana University/IU Health Physicians, Indianapolis, IN.
Urology. 2019 Dec;134:62-65. doi: 10.1016/j.urology.2019.08.044. Epub 2019 Sep 16.
To evaluate feasibility of percutaneous nephrolithotomy (PCNL) for complex nephrolithiasis in patients 80 years of age and older compared to younger individuals.
From an institutional IRB-approved database, 1,647 patients were identified who underwent PCNL from 1999 to 2019. Patients were stratified by age: group 1 (20-59), group 2 (60-79), and group 3 (>80). Statistics were performed using chi-square and ANOVA to compare outcomes.
Of the 1,647 patients, median age was 46, 66, and 83, respectively (P <0.0001). Three patients within group 3 were 90 or older. Females made up 54%, 46%, 56% of patients (P = 0.02). Average stone size with SD was 2.6 ± 2.2, 2.5 ± 2.3, 2.2± 1.9 cm for each group (P = 0.06). Mean preoperative hemoglobin (Hgb) was significantly lower in the 80+ group (13.8, 13.4, 13.1 g/dL, P <.0001). Change in Hgb was not significantly different. There were more Clavien II-IV complications (10.4, 14.4, 28.8%; P = 0.02) and transfusions (2.3, 4.7, 10.2%; P <0.001) in the elderly. The most common complications in the 80+ group were bleeding related (10.1%). No difference in readmission rates or ICU admissions was noted.
PCNL is feasible in the extremely elderly; however with a higher rate of complications and longer hospitalizations. No long-term sequelae or deaths in the 80 and older cohort were seen. This study allows us to appropriately counsel older patients on a realistic postoperative course and supports use of PCNL as the best means of long-term survival.
评估 80 岁及以上高龄患者与年轻患者相比行经皮肾镜取石术(PCNL)治疗复杂性肾结石的可行性。
从机构审查委员会批准的数据库中,确定了 1647 名于 1999 年至 2019 年期间接受 PCNL 的患者。根据年龄将患者分为 3 组:组 1(20-59 岁)、组 2(60-79 岁)和组 3(>80 岁)。使用卡方检验和方差分析进行统计学比较。
在 1647 名患者中,中位年龄分别为 46、66 和 83 岁(P<0.0001)。组 3 中有 3 名患者年龄在 90 岁以上。女性分别占患者的 54%、46%和 56%(P=0.02)。每组的平均结石大小(标准差)分别为 2.6±2.2、2.5±2.3 和 2.2±1.9cm(P=0.06)。80 岁以上组的术前血红蛋白(Hgb)明显较低(13.8、13.4、13.1g/dL,P<0.0001)。Hgb 的变化无显著差异。高龄组有更多的 Clavien II-IV 级并发症(10.4%、14.4%、28.8%;P=0.02)和输血(2.3%、4.7%、10.2%;P<0.001)。80 岁以上组最常见的并发症是出血相关(10.1%)。未观察到再入院率或 ICU 入院率的差异。
PCNL 对极高龄患者可行,但并发症发生率较高,住院时间较长。80 岁及以上患者未出现长期后遗症或死亡。本研究使我们能够为老年患者提供现实的术后过程,并支持将 PCNL 作为长期生存的最佳手段。